BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

  March 31, 2025

   · 

  1 min read
• Press Releases

  Labcorp to Announce First Quarter Financial Results on April 29, 2025

  March 31, 2025

   · 

  1 min read
• Press Releases

  Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage

  March 31, 2025

   · 

  4 min read
• Press Releases

  ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

  March 31, 2025

   · 

  7 min read
• Press Releases

  DESTINY-Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer

  March 31, 2025

   · 

  19 min read
• Press Releases

  Quantum BioPharma Provides Corporate Update

  March 31, 2025

   · 

  4 min read
• Press Releases

  Vertex Announces Program Updates for Type 1 Diabetes Portfolio

  March 31, 2025

   · 

  7 min read
• Press Releases

  HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress

  March 31, 2025

   · 

  5 min read
• Press Releases

  Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

  March 31, 2025

   · 

  11 min read
• Press Releases

  Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025

  March 31, 2025

   · 

  7 min read